News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Tern Therapeutics Launches with $15 Million in Financing and CLN2 Batten Disease Treatment Pipeline from REGENXBIO
Tern Therapeutics, a biotechnology company focused on developing gene therapies for rare diseases, recently launched with $15 million in financing.
Dr. James Wilson takes on roles in two new companies spun out of Penn’s Gene Therapy Program
James Wilson, MD, PhD, has left Penn after 33 years to take on leadership roles in two independent startups that he co-founded.
Penn Medicine and Parker Institute renew alliance to continue advancing groundbreaking cancer immunotherapy research
Penn Medicine and the Parker Institute for Cancer Immunotherapy (PICI) have renewed their collaboration to advance cancer immunotherapy research at Penn Medicine’s Abramson Cancer Center (ACC).
Fast Company and Inc Rank Penn as Second on The Ignition Schools List
The list ranks “top academic institutions that play an enormous role in shaping the businesses that influence society”.
PCI Mourns the Loss of Eric Corkhill, former Chairman and CEO of Neuralert Technologies
he Penn Center for Innovation is deeply saddened by the passing of Eric Corkhill, who served as Chairman and CEO of Neuralert Technologies.
Press Highlights of FY24
During the 2022 fiscal year, there were 98 press mentions for PCI programs, startups and partners. Some of the most popular and widely circulated stories are included here.
Penn Medicine and Parker Institute renew alliance to continue groundbreaking cancer immunotherapy research
The continued collaboration will support laboratory studies and clinical trials that leverage the science of cancer immunology.
Penn Medicine researchers use AI to uncover potential antibiotic compounds
This groundbreaking study, published in Cell, represents the largest antibiotic discovery effort to date, significantly accelerating the process of identification of candidate molecules.
Penn Engineering’s Professors Discuss Innovations Over Tea
Their “brewing” collaboration recently led to the development of a novel chip that uses light for vector-matrix multiplication.
Penn Researchers Study New Treatment Options for Brain Cancer Patients
A team of Penn researchers are exploring whether MRIs that measure the "temperature" of tumors could enhance treatment for glioblastoma, a deadly brain cancer.